Fig. 1From: A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeuticSDS-PAGE and western blotting analysis of protein expression a SDS-PAGE: M: protein molecular weight marker; #1, 2: Lysates of E. coli cells after and before induction of VGRmIL2-IC expression #3: Purified VGRmIL2-IC protein; #4: Lysate of E. coli cells after induction of wtIL-2 expression; #5, 6: Lysate of E. coli cells after induction of mIL-2 expression; 7: Purified mIL-2 b Western blotting analysis: #1; Purified wtIL-2; #2: Purified mIL-2; #3: Purified VGRmIL2-ICBack to article page